Combined targeted therapy and immunotherapy in the treatment of advanced melanoma

Recently, a CTLA-4 antibody and BRAF inhibitors showed survival benefits in advance melanoma treatment. The documentation of immune infiltrates in melanomas early during BRAF inhibitor therapy provides a scientific rationale for combination therapy with both treatments with possible synergistic bene...

Full description

Saved in:
Bibliographic Details
Main Authors: Wilmott, James S., Scolyer, Richard A., Long, Georgina V., Hersey, Peter
Format: Artigo
Language:Inglês
Published: Landes Bioscience 2012
Subjects:
Author's View
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3489773/
https://ncbi.nlm.nih.gov/pubmed/23189245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.19865
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items